US Physical Therapy (USPH)

Common Shares
Sell: $39.88|Buy: $82.02|Change: 0.36 (0.51%)

Open 

$70.91


Previous close 

$71.24


Trade high 

$72.045


Volume 

85,743


Year high 

$108.135


Year low 

$62.77


Dividend yield 

2.48%


Market capitalisation 

$1.09 bn


P/E ratio 

38.72


ISIN 

US90337L1089


Share price

Dividends

PreviousLatest
Record date15/11/202414/03/2025
Ex-dividend date15/11/202414/03/2025
Payment date06/12/202411/04/2025
Amount$0.44$0.45

Performance 29/04/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
US Physical Therapy+ 0.51
More...

Company profile

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.